S-Alpha Therapeutics

S-Alpha Therapeutics is a company that researches and develops health applications and digital therapeutics. The company has developed a variety of digital therapeutic products in its R&D pipeline, which are treatment interventions that integrate biology and information technology. Currently, the company is conducting clinical trials at multiple clinical sites in South Korea to evaluate the efficacy, safety, and feasibility of SAT-001. In the company’s product pipeline, SAT-008, developed with the aim of inducing individual immune enhancement, is establishing a business development model based on evidence from clinical studies in South Korea.